Literature DB >> 6965227

Immunoselection of tumor variants resistant to antibody-mediated cytotoxicity. Their immunologic and metastatic characterization.

J R Starkey1, W C Davis, J E Talmadge.   

Abstract

The immunological characteristics of two series of metastatic variants of restricted genetic origin were related to their lung-colony-forming potential. A series of metastatic variants was isolated from a tumor-cell population in which heterogeneity appeared following short-term in vivo passage, while a second series of variants were immunoselected in vitro for resistance to antibody-complement-mediated cell lysis. In the case of the first series, the sensitivity of the individual variants to cell-mediated and antibody-complement-mediated cytotoxicity appeared to be partly determined by the number and rate of loss of antibody-binding sites on the cell surface. These characteristics also correlated with the efficiency of experimental metastasis in the animal. We compared the results reported herein with our previous studies of nonimmune parameters for this series of metastatic variants, and we conclude that immunological differences can be important to the efficiency of lung-colony formation. However, in the case of the second series of variants, despite selection in vitro for resistance to antibody-complement-mediated cell lysis, the behavior of these variants in the lung colony assay could not be predicted by the immunologic parameters examined.

Entities:  

Mesh:

Year:  1982        PMID: 6965227     DOI: 10.1007/BF00200180

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  40 in total

1.  Circulating immune complexes in rats bearing chemically induced tumors. I. Sequential determination during the growth of tumours at various body sites.

Authors:  K Höffken; M R Price; P J McLaughlin; V E Moore; R W Baldwin
Journal:  Int J Cancer       Date:  1978-04-15       Impact factor: 7.396

2.  Mechanism of tumor cell resistance to lysis by syngeneic lymphocytes.

Authors:  I J Fidler; C Bucana
Journal:  Cancer Res       Date:  1977-11       Impact factor: 12.701

3.  Circulating immune complexes in rats bearing chemically induced tumours. II. Characterization of sera from different stages of tumour growth.

Authors:  K Höffken; M R Price; V E Moore; R W Baldwin
Journal:  Int J Cancer       Date:  1978-11-15       Impact factor: 7.396

4.  The C1q binding test for soluble immune complexes: clinical correlations obtained in patients with cancer.

Authors:  R D Rossen; M A Reisberg; E M Hersh; J U Gutterman
Journal:  J Natl Cancer Inst       Date:  1977-05       Impact factor: 13.506

5.  Classes and subclasses of rat antibodies: reaction with the antigen and interaction of the complex with the complement system.

Authors:  G A Medgyesi; K Miklós; J Kulics; G Füst; J Gergely; H Bazin
Journal:  Immunology       Date:  1981-05       Impact factor: 7.397

6.  Characterization in vivo and in vitro of tumor cells selected for resistance to syngeneic lymphocyte-mediated cytotoxicity.

Authors:  I J Fidler; D M Gersten; M B Budmen
Journal:  Cancer Res       Date:  1976-09       Impact factor: 12.701

Review 7.  The pathogenesis of cancer metastasis.

Authors:  G Poste; I J Fidler
Journal:  Nature       Date:  1980-01-10       Impact factor: 49.962

8.  Circulating immune complexes in patients with bone tumours.

Authors:  A S Eiras; R A Robins; R W Baldwin; V S Byers
Journal:  Int J Cancer       Date:  1980-06-15       Impact factor: 7.396

9.  Circulating immune complexes in sera of dogs with benign and malignant breast disease.

Authors:  B R Gordon; S Moroff; A I Hurvitz; R E Matus; E G MacEwen; R A Good; N K Day
Journal:  Cancer Res       Date:  1980-10       Impact factor: 12.701

10.  Enhancement of tumor outgrowth by tumor-associated blocking factors.

Authors:  K E Hellström; I Hellström
Journal:  Int J Cancer       Date:  1979-03-15       Impact factor: 7.396

View more
  2 in total

1.  Immunologic enhancement of experimental metastasis in the rat.

Authors:  J R Starkey; S S Ristow; T L McDonald; J E Talmadge
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

2.  Changes in adhesive properties of tumor cells do not necessarily influence metastasizing capacity.

Authors:  M Zöller; S Matzku
Journal:  Clin Exp Metastasis       Date:  1989 Mar-Apr       Impact factor: 5.150

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.